Clinical Trial Update: Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema [Phase 3]

View source ↗

Summary

Phase 3 study of the Biologic Lung Volume Reduction System for advanced upper lobe predominant emphysema has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Emphysema

Drugs mentioned

• Biologic Lung Volume Reduction System (BLVR System) (Biologic Lung Volume Reduction System)

Snippet

Sponsor: Aeris Therapeutics | Conditions: Advanced Upper Lobe Predominant Emphysema | Phase 3 | Status: WITHDRAWN